PP
ALXN

Prudential plc’s Alexion Pharmaceuticals ALXN Stock Holding History

Prudential plc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,436
Closed -$1.32M – 680
2020
Q4 		$1.32M Hold
8,436
– – 0.01% 428
2020
Q3 		$965K Sell
8,436
-484
-5% -$52.2K ﹤0.01% 437
2020
Q2 		$1M Buy
+8,920
New +$947K ﹤0.01% 414
2019
Q4 		– Sell
-103,632
Closed -$10.2M – 804
2019
Q3 		$10.2M Sell
103,632
-7,811
-7% -$880K 0.03% 325
2019
Q2 		$14.6M Hold
111,443
– – 0.04% 279
2019
Q1 		$15.1M Sell
111,443
-68,491
-38% -$8.52M 0.05% 228
2018
Q4 		$17.5M Buy
+179,934
New +$21.3M 0.07% 203
2017
Q4 		– Sell
-1,484
Closed -$208K – 748
2017
Q3 		$208K Buy
+1,484
New +$202K ﹤0.01% 664
2016
Q1 		– Sell
-1,683
Closed -$321K – 634
2015
Q4 		$321K Hold
1,683
– – ﹤0.01% 517
2015
Q3 		$263K Buy
1,683
+423
+34% +$77.2K ﹤0.01% 479
2015
Q2 		$228K Hold
1,260
– – ﹤0.01% 509
2015
Q1 		$218K Hold
1,260
– – ﹤0.01% 506
2014
Q4 		$233K Hold
1,260
– – ﹤0.01% 468
2014
Q3 		$209K Sell
1,260
-148
-11% -$24.3K ﹤0.01% 485
2014
Q2 		$220K Hold
1,408
– – ﹤0.01% 476
2014
Q1 		$214K Buy
+1,408
New +$224K ﹤0.01% 470

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential plc's ALXN Position: Q1 2021 in Review

Prudential plc sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 8,436 shares — an estimated $1.32M sold.

Prudential plc first reported a position in ALXN in Q1 2014 and held it in 16 quarters. The position peaked at $17.5M in Q4 2018. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Prudential plc reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Prudential plc sold 8,436 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.32M.
  • Prudential plc first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 16 quarters.
  • Prudential plc's Alexion Pharmaceuticals position peaked at $17.5M in Q4 2018.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Prudential plc's 13F filing for Q1 2021, filed 14 May 2021.